PSMB7 Is a Key Gene Involved in the Development of Multiple Myeloma and Resistance to Bortezomib

Multiple myeloma (MM), the second most commonly diagnosed hematologic neoplasm, is the most significant clinical manifestation in a series of plasma cell (PC) dyscrasia. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering MM (SMM), approximately 1% or 10% of which, respectively,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Dong, Miao, Jiyu, Hu, Jinsong, Li, Fangmei, Gao, Dandan, Chen, Hongli, Feng, Yuandong, Shen, Ying, He, Aili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343178/
https://www.ncbi.nlm.nih.gov/pubmed/34367968
http://dx.doi.org/10.3389/fonc.2021.684232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343178/
https://www.ncbi.nlm.nih.gov/pubmed/34367968
http://dx.doi.org/10.3389/fonc.2021.684232

Ejemplares similares